Molecular Diagnostics
New DNA Biosensor Could Make High-Quality Clinical Diagnostics More Accessible
Typical screening methods for DNA disease biomarkers are often laborious, expensive or uncover limited information. Now, a new biosensor chip featuring an accurate and inexpensive design has the potential to improve accessibility to high-quality diagnostics. More...26 Jan 2023
Non-Invasive Blood Test Helps Select Treatment for Advanced Gastrointestinal Stromal Tumors
A new study has found that using a blood-based test can help select the appropriate treatment for patients with advanced gastrointestinal stromal tumor (GIST) which is a specific type of tumor that forms in the gastrointestinal tract. More...26 Jan 2023
Non-Invasive Melanoma Test Ushers in New Era in Skin Cancer Detection
Skin cancer overall is the most common form of cancer with melanoma being the third most common and also the most aggressive form of skin cancer. Now, an innovative test painlessly collect cells from the skin and applies precision genomics to diagnose melanoma accurately and at the earliest curable stage. More...25 Jan 2023
World’s First Molecular, Cell-Based Test Offers Non-Surgical Method for Diagnosis and Staging of Endometriosis
Hera Biotech is developing and commercializing the world’s first non-surgical test for the definitive diagnosis and staging of endometriosis. Hera’s breakthrough approach is based on cutting edge, single cell, micro-fluidic analysis to identify endometriosis-specific biological markers, enabling clinicians to definitively diagnose endometriosis regardless of stage with unparalleled accuracy. More...25 Jan 2023
Rapid POC Diagnostic Assay Could Detect and Measure Fentanyl Neutralizing Antibodies
AXIM Biotechnologies, Inc. is leveraging its experience in diagnostics and working with neutralizing antibodies to develop a rapid point-of-care diagnostic assay that will detect and measure the levels of fentanyl neutralizing antibodies. More...23 Jan 2023
Molecular Diagnostic Platform for Automated Sample Processing to Help Labs Achieve New Flexibility Level
QIAGEN N.V. (Venlo, Netherlands) has launched EZ2 Connect MDx for use in diagnostic laboratories, making the IVD platform for automated sample processing available for wide scale use 18 months after it was first made available for research. The EZ2 Connect MDx offers a high degree of automation, enabling labs to purify DNA and RNA from 24 samples in parallel in as less as 30 minutes. More...23 Jan 2023
New
Gold Member
Troponin T QC
Troponin T Quality Control
New
Gold Member
Thyroid Stimulating Hormone Assay
TSH EIA 96 Test
New
Lab Autoclave
T-Lab Eco
In Other News
Early Alzheimer’s Detection Sensor Could Also Diagnose Other Diseases at POC
First-Of-A-Kind Pan-Cancer Blood Test Could Predict Immunotherapy Efficacy and Toxicity
World’s First Test Detects Diabetics at Risk of Kidney Disease before Symptoms Appear
ELISAs Reliably Detect Anti-CCHFV Antibodies in Acute Infections
New Blood Test Tracks and Follows Neurodegeneration in Alzheimer's
Electrochemical Cell-Free Biosensor Directly Detects Influenza Antibodies in Blood at POC
Highly Accurate Test "Fishes" For Respiratory Viruses Using DNA as Bait
Cheap, Easy Blood Test Detects Cancer by Identifying Broken DNA
Simple Blood Test Could Screen for Common and Dangerous Pregnancy Complications
Genetic Test Improves Ovarian Cancer Treatment
Blood Test Could Detect Alzheimer's 10 Years Before Symptoms Show
Blood Microbiome-Driven Liquid Biopsy Assay Detects Lung Cancer in Earliest Stages
BD, CerTest Announce Emergency Use Authorization for Mpox Diagnostic Test
New Database Provides First-Ever Map of Proteome Signature in Blood from Cancer Patients
Raman Spectroscopy Test Could Improve Lyme Disease Diagnostics
Rapid Diagnostic Test Uses Light to Detect Malaria without Blood Samples
First Blood Panel to Detect Deadly Placenta Accreta Spectrum
Amniotic Fluid Cells RNA-Sequencing Demonstrates Diagnostic Potential in Deciphering Rare Diseases
Single Immune System Molecule on Nasal Swabs Detects Stealthy Viruses Not Identified in Standard Tests
CRISPR Protein Could Yield New Tests for Many Viruses
Nanopore Sequencing Detect Pathogens in Knee Periprosthetic Joint Infection
Multi-Cancer Detection Blood Test to Enable Early Diagnosis and Treatment
Blood-Based Screening Test for Colorectal Cancer Demonstrates Strong Clinical Performance
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
